← Peptide Library
SIGNALLING RESEARCHCJC
CJC-1295 + Ipamorelin
A combined research blend of CJC-1295 (a GHRH analog) and Ipamorelin (a selective GHRP), studied for synergistic growth-hormone axis signalling and pulsatile release patterns.
Half-Life
Moderate–Long
Onset
Gradual
Symbol
CJC
Category
Signalling
⏱ Half-Life
Moderate–Long duration profile
CJC-1295 + Ipamorelin demonstrates a moderate–long half-life characteristic in research literature, shaping how observation windows and study timelines are typically structured.
⚡ Onset Characteristics
Gradual measurable response
Onset is observed as gradual — a property that influences how researchers structure comparative studies versus other compounds in the signalling research category.
🧠 Key Notes
What makes it distinct
- 01Combines a GHRH analog with a selective GHRP for additive signalling
- 02Ipamorelin is studied for its selective profile vs other GHRPs
- 03Frequently referenced in long-duration endocrine research
Continue Exploring
Also explore: MOTS-c, TB-500, Retatrutide